Full Press Release Details
| Contacts: | ||||
| Investor Relations | Media Relations | |||
| Kristy Moser | Ventura Olvera | |||
| Kristine.moser@petco.com | Ventura.olvera@petco.com |
FOR IMMEDIATE RELEASE: March 18, 2021
PETCO HEALTH + WELLNESS COMPANY, INC. Reports Strong Fourth Quarter and Full-Year 2020 Results, Issues 2021 Guidance
Fourth quarter revenue and comp sales increased 16% and 17%, respectively
Digital sales grew over 90%; Acquired approximately 1 million new customers in the quarter
Fiscal 2020 revenue and comp sales both grew 11%, reflecting continued success of Petco s transformation into an omnichannel Health and
San Diego, CA (March 18, 2021) Petco Health and Wellness Company, Inc. (NASDAQ: WOOF), a complete partner in pet health and
wellness, today released its financial results for fourth quarter and fiscal 2020 ended January 30, 2021.
The company delivered fourth quarter
comparable sales growth of 17 percent and net revenue growth of 16 percent, marking the ninth consecutive quarter of growth for Petco. A $17.5 million loss on the extinguishment of debt related to the company s initial public
offering contributed to a net loss of $6.2 million or $0.03 per share, an improvement of 14 percent and 17 percent, respectively. Adjusted Net Income1 increased 103 percent
from prior year to $37.0 million or $0.17 per share, while fourth quarter Adjusted EBITDA1 increased 13 percent to $148.6 million from prior year.
Fiscal year 2020 revenue increased 11 percent from prior year to $4.9 billion. A net loss of $26.5 million or $0.13 per share improved
72 percent and 73 percent, respectively, and was also inclusive of a $17.5 million loss on the extinguishment of debt related to the company s initial public offering. That 11 percent growth translated to a 14 percent
improvement in Adjusted EBITDA1 to $484.3 million, as well as a $68.0 million improvement in Adjusted Net Income1 to
$58.1 million or $0.28 per share, reflecting the strength of Petco s multi-channel pet care ecosystem.
On the heels of a successful IPO
in January, we closed the year with a strong fourth quarter, and that momentum has carried into 2021, said Ron Coughlin, Chairman and Chief Executive Officer of Petco. Our comprehensive petcare ecosystem focused on health and wellness,
coupled with our digitally-led, multichannel experience is resonating with pet parents and generating significant competitive advantages that are evident in our performance. Our category continues to grow
powered by the millions of incremental new pets in households, which is creating an annuity for years to come. Whether it is eliminating products with artificial ingredients3, rapidly expanding
vet clinics, training, grooming or customer-first fulfillment options like same-day delivery, we re expanding the ways we take care of beloved pets and stepping up to meet increased demand making Petco
well positioned for long-term growth.
In addition, Petco reduced total debt by 49 percent to $1.7 billion and Net Debt1 by 50 percent to $1.5 billion using the proceeds from the company s initial public offering, the recapitalization of a portion of debt outstanding at the time of the initial public
offering and Free Cash Flow1 generation. Net Debt1 reduction and Adjusted EBITDA1
improvement led to a decrease of 4.2x in Petco s Net Debt1 to Adjusted EBITDA1 ratio to 3.2x. On March 4th, Petco announced the successful completion of the company s debt refinancing transaction which extended the maturity dates of the company s term loan to 2028 and revolving credit facility
Fiscal Q4 2020 Highlights:
are fourth quarter of 2020 ended January 30, 2021 versus fourth quarter of 2019 ended February 1, 2020 unless otherwise noted
Fiscal Year 2020 Highlights:
Comparisons are fiscal year of 2020 ended January 30, 2021 versus fiscal year of 2019 ended February 1, 2020 unless otherwise noted
Fiscal 2021 Guidance:
The following guidance as of March 18, 2021 reflects the company s expectations for fiscal year 2021 unless otherwise indicated.
| Metric | Guidance | |||
| Revenue | $ | 5.25 billion - $5.35 billion | ||
| Adjusted EBITDA 2 | $ | 520 million - $530 million | ||
| Adjusted EPS 2 | $ | 0.63 - $0.66 |
Assumptions in the guidance include that economic conditions, currency rates and the tax and regulatory landscape remain
generally consistent. The company continues to monitor those assumptions and any potential financial impacts. Adjusted EPS guidance assumes approximately $90 million of interest expense, a 26% tax rate and 266 million weighted
average diluted share count.
Earnings Conference Call Webcast Information:
company will host an earnings conference call on March 18, 2021 at 8:30 AM Eastern Time to discuss Petco s financial results. The conference call will be accessible through live webcast. Interested investors and other individuals can
access the webcast, earnings press release, and earnings presentation via the company s investor relations page (https://ir.petco.com/investor-relations). A replay of the webcast will be archived on the company s website through
April 1, 2021 at 5:00 PM Eastern Time.
Petco is a category-defining health and wellness company focused on improving the lives of pets, pet parents and our own Petco partners. Since our founding in
1965, we ve been trailblazing new standards in pet care, delivering comprehensive wellness solutions through our products and services, and creating communities that deepen the pet-pet parent bond. We
operate more than 1,500 Petco locations across the U.S., Mexico, and Puerto Rico, including a growing network of more than 100 in-store veterinary hospitals, and offer a complete online resource for pet health
and wellness at petco.com and on the Petco app. In tandem with The Petco Foundation, an independent nonprofit organization, we work with and support thousands of local animal welfare groups across the country and, through in-store adoption events, we ve helped find homes for more than 6.5 million animals.
Forward Looking Statements
This earnings release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 as contained
in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, concerning expectations, beliefs plans, objectives, goals, strategies, future events or performance and
underlying assumptions and other statements that are not statements of historical fact. Although the company believes that the expectations and assumptions reflected in these statements are reasonable, there can be no assurance that these
expectations will prove to be correct. There can be no assurance that any forward-looking results will occur or be realized, and nothing contained in this earnings release is, or should be relied upon as, a promise or representation or warranty as
to any future matter, including any matter in respect of the operations or business or financial condition of Petco. Such forward-looking statements can be identified by the use of forward-looking terms such as believes,
expects, may, intends, will, shall, should, anticipates, opportunity, illustrative , or the negative thereof or other variations thereon or
comparable terminology. All forward-looking statements are based on assumptions or judgments about future events that may or may not be correct or necessarily take place and that are by their nature subject to significant uncertainties and
contingencies, many of which are outside the control of Petco. Forward-looking statements are subject to a number of risks, uncertainties and other factors that could cause actual results to differ materially from the potential results discussed in
the forward-looking statements, including, without limitation, those identified in this earnings release, the risk factors that the company identifies in its Securities and Exchange Commission filings, as well as the following: (i) increased
competition (including from multi-channel retailers and e-Commerce providers); (ii) reduced consumer demand for our products and/or services; (iii) our reliance on key vendors; (iv) our ability to
attract and retain qualified employees; (v) risks arising from statutory, regulatory and/or legal developments; (vi) macroeconomic pressures in the markets in which we operate; (vii) failure to effectively manage our costs;
(viii) our reliance on our information technology systems; (ix) our ability to prevent or effectively respond to a privacy or security breach; (x) our ability to effectively manage strategic ventures, alliances or acquisitions;
(xi) economic or regulatory developments that might affect our ability to provide attractive promotional financing; (xii) interruptions and other supply chain issues; (xiii) catastrophic events, health crises, and pandemics, including
the potential effects that the ongoing COVID-19 pandemic and/or corresponding macroeconomic uncertainty could have on our financial position, results of operations and cash flows; (xiv) our ability to
maintain positive brand perception and recognition; (xv) product safety and quality concerns; (xvi) changes to labor or employment laws or regulations; (xvii) our ability to effectively manage our real estate portfolio;
(xviii) constraints in the capital markets or our vendor credit terms; and (xix) changes in our credit ratings. The occurrence of any such factors, events, or circumstances would significantly alter the results set forth in these
Petco cautions that the foregoing list of important factors is not complete, and any forward-looking statements speak only as of the date
they are made. Petco undertakes no duty to update publicly any forward-looking statement that it may make, whether as a result of new information, future events or otherwise, except as may be required by applicable law, regulation or other competent
PETCO HEALTH AND WELLNESS COMPANY, INC.
CONDENSED CONSOLIDATED STATEMENT OF EARNINGS
(In millions, except per share amounts)
(Unaudited and subject to reclassification)
| 13 Weeks Ended | 52 Weeks Ended | |||||||||||||||||||||||
| January 30, 2021 | February 1, 2020 | Percent Change | January 30, 2021 | February 1, 2020 | Percent Change | |||||||||||||||||||
| Net Sales | $ | 1,337.7 | $ | 1,148.7 | 16 | % | $ | 4,920.2 | $ | 4,434.5 | 11 | % | ||||||||||||
| Cost of goods sold | 768.4 | 650.8 | 18 | % | 2,813.5 | 2,528.0 | 11 | % | ||||||||||||||||
| Gross profit | 569.3 | 497.9 | 14 | % | 2,106.7 | 1,906.5 | 11 | % | ||||||||||||||||
| Selling, general and administrative expenses | 502.3 | 437.8 | 15 | % | 1,912.3 | 1,776.9 | 8 | % | ||||||||||||||||
| Goodwill and indefinite-lived intangible impairment | 19.0 | NA | 19.0 | NA | ||||||||||||||||||||
| Operating income | 67.0 | 41.1 | 63 | % | 194.4 | 110.6 | 76 | % | ||||||||||||||||
| Interest expense, net | 49.7 | 60.7 | (18 | %) | 218.4 | 252.7 | (14 | %) | ||||||||||||||||
| Loss on extinguishment of debt | 17.5 | NA | 17.5 | NA | ||||||||||||||||||||
| Loss before income from equity method investees | (0.2 | ) | (19.5 | ) | (99 | %) | (41.6 | ) | (142.1 | ) | (71 | %) | ||||||||||||
| Income tax expense/(benefit) | 10.2 | (7.4 | ) | NA | (3.3 | ) | (35.7 | ) | (91 | %) | ||||||||||||||
| Income from equity method investees | (3.5 | ) | (2.1 | ) | 67 | % | (6.5 | ) | (2.4 | ) | 166 | % | ||||||||||||
| Net loss | (6.9 | ) | (10.0 | ) | (31 | %) | (31.7 | ) | (104.0 | ) | (69 | %) | ||||||||||||
| Net Loss Attributable to Noncontrolling Interest | (0.8 | ) | (2.8 | ) | (74 | %) | (5.3 | ) | (8.1 | ) | (35 | %) | ||||||||||||
| Net Loss Attributable to Class A and B-1 common shareholders | $ | (6.2 | ) | $ | (7.2 | ) | (14 | %) | $ | (26.5 | ) | $ | (95.9 | ) | (72 | %) | ||||||||
| Net Loss Per Class A and B-1 Common Share: | ||||||||||||||||||||||||
| Basic earnings per share | $ | (0.03 | ) | $ | (0.03 | ) | (17 | %) | $ | (0.13 | ) | $ | (0.46 | ) | (73 | %) | ||||||||
| Diluted earnings per share | $ | (0.03 | ) | $ | (0.03 | ) | (17 | %) | $ | (0.13 | ) | $ | (0.46 | ) | (73 | %) | ||||||||
| Weighted-Average Common Shares Outstanding: | ||||||||||||||||||||||||
| Basic | 215.7 | 209.0 | 3 | % | 210.7 | 208.9 | 1 | % | ||||||||||||||||
| Diluted | 215.7 | 209.0 | 3 | % | 210.7 | 208.9 | 1 | % |
PETCO HEALTH AND WELLNESS COMPANY, INC.
CONSOLIDATED BALANCE SHEET
subject to reclassification)
| January 30, 2021 | February 1, 2020 | |||||||
| ASSETS | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | 111,402 | $ | 148,785 | ||||
| Receivables, less allowance for credit losses 1 | 41,827 | 31,516 | ||||||
| Merchandise inventories, net | 538,675 | 478,968 | ||||||
| Prepaid expenses | 40,032 | 24,854 | ||||||
| Other current assets | 45,613 | 26,882 | ||||||
| Total current assets | 777,549 | 711,005 | ||||||
| Fixed assets, net | 627,547 | 656,256 | ||||||
| Operating lease right-of-use assets | 1,328,108 | 1,459,604 | ||||||
| Goodwill | 2,179,310 | 2,179,310 | ||||||
| Trade name | 1,025,000 | 1,025,000 | ||||||
| Other intangible assets, net | 714 | 1,553 | ||||||
| Other long-term assets | 137,474 | 122,390 | ||||||
| Total assets | $ | 6,075,702 | $ | 6,155,118 | ||||
| LIABILITIES AND EQUITY | ||||||||
| Current liabilities: | ||||||||
| Accounts payable and book overdrafts | $ | 339,485 | $ | 293,203 | ||||
| Accrued salaries and employee benefits | 129,484 | 93,685 | ||||||
| Accrued expenses and other liabilities | 145,846 | 148,181 | ||||||
| Current portion of operating lease liabilities | 258,289 | 278,229 | ||||||
| Current portion of long-term debt and other lease liabilities | 2,203 | 28,643 | ||||||
| Total current liabilities | 875,307 | 841,941 | ||||||
| Senior secured credit facilities, net, excluding current portion | 1,646,281 | 2,362,302 | ||||||
| Senior notes, net | 866,145 | |||||||
| Operating lease liabilities, excluding current portion | 1,083,575 | 1,156,742 | ||||||
| Deferred taxes, net | 280,920 | 265,276 | ||||||
| Other long-term liabilities | 134,354 | 101,651 | ||||||
| Total liabilities | 4,020,437 | 5,594,057 | ||||||
| Stockholders equity / members equity: | ||||||||
| Members interest | 1,358,130 | |||||||
| Class A common stock 2 | 226 | |||||||
| Class B-1 common stock 3 | 38 | |||||||
| Class B-2 common stock 4 | ||||||||
| Preferred stock 5 | ||||||||
| Additional paid-in-capital | 2,092,110 | |||||||
| Accumulated deficit | (22,251 | ) | (780,466 | ) | ||||
| Accumulated other comprehensive loss | (1,275 | ) | (8,273 | ) | ||||
| Total stockholders equity / members equity | 2,068,848 | 569,391 | ||||||
| Noncontrolling interest | (13,583 | ) | (8,330 | ) | ||||
| Total equity | 2,055,265 | 561,061 | ||||||
| Total liabilities and equity | $ | 6,075,702 | $ | 6,155,118 |
PETCO HEALTH AND WELLNESS COMPANY, INC.
CONSOLIDATED STATEMENT OF CASH FLOWS
subject to reclassification)
| January 30, 2021 | February 1, 2020 | |||||||
| Cash flows from operating activities: | ||||||||
| Net loss | $ | (31,736 | ) | $ | (103,984 | ) | ||
| Adjustments to reconcile net loss to net cash provided by operating activities: | ||||||||
| Depreciation and amortization | 174,836 | 173,544 | ||||||
| Amortization of debt discounts and issuance costs | 24,237 | 23,455 | ||||||
| Provision for deferred taxes | 25,548 | (45,087 | ) | |||||
| Equity-based compensation | 12,915 | 9,489 | ||||||
| Impairments, write-offs and losses on sale of fixed and other assets | 15,606 | 11,871 | ||||||
| Loss on extinguishment of debt | 17,549 | |||||||
| (Income) loss from equity method investees | (6,482 | ) | (2,441 | ) | ||||
| Amounts reclassified out of accumulated other comprehensive income | 10,793 | 2,806 | ||||||
| Change in contingent consideration obligation | (398 | ) | 883 | |||||
| Goodwill and indefinite-lived intangible impairment | 19,000 | |||||||
| Non-cash operating lease costs | 430,359 | 441,981 | ||||||
| Changes in assets and liabilities: | ||||||||
| Receivables | (10,311 | ) | (3,845 | ) | ||||
| Merchandise inventories | (60,635 | ) | (8,193 | ) | ||||
| Prepaid expenses and other assets | (13,842 | ) | (5,223 | ) | ||||
| Accounts payable and book overdrafts | 46,303 | 15,928 | ||||||
| Accrued salaries and employee benefits | 34,295 | (1,395 | ) | |||||
| Accrued expenses and other liabilities | (28,289 | ) | (3,043 | ) | ||||
| Operating lease liabilities | (399,557 | ) | (408,562 | ) | ||||
| Other long-term liabilities | 27,424 | (6,847 | ) | |||||
| Net cash provided by operating activities | 268,615 | 110,337 | ||||||
| Cash flows from investing activities: | ||||||||
| Cash paid for fixed assets | (159,560 | ) | (156,906 | ) | ||||
| Cash paid for intangible assets | (450 | ) | ||||||
| Insurance recoveries | 489 | |||||||
| Cash paid for other acquisitions, net of cash acquired | (2,813 | ) | ||||||
| Cash from consolidation of joint venture | 1,205 | |||||||
| Cash paid for investments | (1,000 | ) | (585 | ) | ||||
| Proceeds from sale of investment | 73 | |||||||
| Proceeds from sale of assets | 3,302 | |||||||
| Proceeds from sale-leasebacks, net | 18,549 | |||||||
| Proceeds from partial surrender of officers life insurance | 1,470 | |||||||
| Net cash used in investing activities | (157,185 | ) | (139,041 | ) | ||||
| Cash flows from financing activities: | ||||||||
| Borrowings under long-term debt agreements | 476,000 | 1,297,000 | ||||||
| Repayments of long-term debt | (1,554,890 | ) | (1,293,250 | ) | ||||
| Debt prepayment, issuance and refinancing costs | (58 | ) | ||||||
| Payments for finance and capital lease liabilities | (3,404 | ) | (3,447 | ) | ||||
| Partial settlement of member note | (809 | ) | ||||||
| Cash received from noncontrolling interest | 243 | |||||||
| Proceeds from initial public offering, net of issuance costs | 936,041 | |||||||
| Repurchase of equity | (105 | ) | ||||||
| Payment of contingent consideration | (250 | ) | (2,750 | ) | ||||
| Net cash used in financing activities | (146,608 | ) | (3,071 | ) | ||||
| Net (decrease) increase in cash, cash equivalents and restricted cash | (35,178 | ) | (31,775 | ) | ||||
| Cash, cash equivalents and restricted cash at beginning of year | 154,718 | 186,493 | ||||||
| Cash, cash equivalents and restricted cash at end of year | $ | 119,540 | $ | 154,718 |
Non-GAAP Financial Measures
The following information provides definitions and reconciliations of the non-GAAP financial measures presented in this
earnings release to the most directly comparable financial measures calculated and presented in accordance with generally accepted accounting principles (GAAP). The company has provided this non-GAAP financial
information, which is not calculated or presented in accordance with GAAP, as information supplemental and in addition to the financial measures presented in the earnings release that are calculated and presented in accordance with GAAP. Such non-GAAP financial measures should not be considered superior to, as a substitute for or alternative to, and should be considered in conjunction with, the GAAP financial measures presented in the earnings release.
The non-GAAP financial measures in the earnings release may differ from similarly-titled measures used by other companies.
Adjusted EBITDA is considered a non-GAAP financial measure under the SEC s rules because it excludes certain charges included in net (loss) income calculated in accordance with GAAP. Management believes that Adjusted EBITDA is a meaningful
measure to share with investors because it best allows comparison with that of the current period performance with that of the comparable period. In addition, Adjusted EBITDA affords investors a view of what management considers Petco s
operating performance to be and the ability to make a more informed assessment of such operating performance as compared with that of the prior period.
Please see the company s Registration Statement on Form filed on January 6, 2021, as amended, for additional information on the reconciliation of
Net Loss Attributable to Class A and B-1 Common Stockholders to Adjusted EBITDA. The table below reflects the calculation of Adjusted EBITDA for the thirteen weeks and fiscal year ended January 30,
2021 compared to prior year ended February 1, 2020.
| (In Thousands) | 13 Weeks Ended | 52 Weeks Ended | ||||||||||||||
| Reconciliation of Net Loss Attributable to Class A and B-1 | January 30, | February 1, | January 30, | February 1, | ||||||||||||
| Common Stockholders to Adjusted EBITDA | 2021 | 2020 | 2021 | 2020 | ||||||||||||
| Net loss attributable to Class A and B-1 common stockholders | $ | (6,159 | ) | $ | (7,171 | ) | $ | (26,483 | ) | $ | (95,873 | ) | ||||
| Add (deduct): | ||||||||||||||||
| Interest expense, net | 49,666 | 60,662 | 218,430 | 252,683 | ||||||||||||
| Income tax expense (benefit) | 10,200 | (7,395 | ) | (3,337 | ) | (35,658 | ) | |||||||||
| Depreciation and amortization | 45,875 | 43,944 | 174,836 | 173,544 | ||||||||||||
| Income from equity method investees | (3,530 | ) | (2,115 | ) | (6,482 | ) | (2,441 | ) | ||||||||
| Loss on debt extinguishment | 17,549 | 17,549 | ||||||||||||||
| Goodwill & indefinite-lived intangible impairment | 19,000 | 19,000 | ||||||||||||||
| Asset impairments and write offs | 7,955 | 2,615 | 15,606 | 11,871 | ||||||||||||
| Equity-based compensation | 5,451 | 2,487 | 12,915 | 9,489 | ||||||||||||
| Mexico Joint Venture EBITDA 1 | 6,655 | 4,787 | 19,074 | 14,227 | ||||||||||||
| Store pre-opening expenses | 2,218 | 2,280 | 9,228 | 10,325 | ||||||||||||
| Store closing expenses | 1,835 | 2,540 | 7,782 | 4,068 | ||||||||||||
| Severance | 1,524 | 1,602 | 5,283 | 10,164 | ||||||||||||
| Non-cash occupancy-related costs 2 | 2,151 | 6,757 | 19,240 | 32,763 | ||||||||||||
| Non-recurring costs 3 | 7,209 | 1,926 | 20,707 | 20,385 | ||||||||||||
| Adjusted EBITDA | $ | 148,599 | $ | 131,919 | $ | 484,348 | $ | 424,547 | ||||||||
| Net sales | $ | 1,337,713 | $ | 1,148,656 | $ | 4,920,202 | $ | 4,434,514 | ||||||||
| Net margin 4 | (0.5 | %) | (0.6 | %) | (0.5 | %) | (2.2 | %) | ||||||||
| Adjusted EBITDA Margin 4 | 11.1 | % | 11.5 | % | 9.8 | % | 9.6 | % |
Adjusted Net Income and Adjusted EPS
Adjusted Net Income and Adjusted diluted earnings per share attributable to Petco (Adjusted Net Income and Adjusted EPS respectively) are considered non-GAAP financial measures under the SEC s rules because they exclude certain amounts included in the net loss attributable to common stockholders and diluted earnings per share attributable to Petco
calculated in accordance with GAAP (net loss and EPS respectively), the most directly comparable financial measures calculated in accordance with GAAP. Management believes that Adjusted Net Income and Adjusted EPS are meaningful measures to share
with investors because they best allow comparison of the current period performance with that of the comparable period. In addition, Adjusted Net Income and Adjusted EPS afford investors a view of what management considers Petco s earnings
performance to be and the ability to make a more informed assessment of such earnings performance with that of the prior period.
The tables below reflect
the calculation of Adjusted Net Income and Adjusted EPS for the thirteen weeks and fiscal year ended January 30, 2021 compared to prior year ended February 1, 2020.
| (In Thousands, except per share amounts) | 13 Weeks Ended | |||||||||||||||
| Reconciliation of GAAP Diluted Loss per Share to Non-GAAP Diluted EPS | January 30, 2021 | February 1, 2020 | ||||||||||||||
| Amount | Per share | Amount | Per share | |||||||||||||
| GAAP net loss attributable to common stockholders / diluted loss per share | $ | (6,159 | ) | $ | (0.03 | ) | $ | (7,171 | ) | $ | (0.03 | ) | ||||
| Add (deduct): | ||||||||||||||||
| Income tax expense (benefit) | 10,200 | 0.05 | (7,395 | ) | (0.04 | ) | ||||||||||
| Loss on debt extinguishment | 17,549 | 0.08 | ||||||||||||||
| Goodwill & indefinite-lived intangible impairment | 19,000 | 0.09 | ||||||||||||||
| Asset impairments and write offs | 7,955 | 0.03 | 2,615 | 0.01 | ||||||||||||
| Equity-based compensation | 5,451 | 0.03 | 2,487 | 0.01 | ||||||||||||
| Store pre-opening expenses | 2,218 | 0.01 | 2,280 | 0.01 | ||||||||||||
| Store closing expenses | 1,835 | 0.01 | 2,540 | 0.01 | ||||||||||||
| Severance | 1,524 | 0.01 | 1,602 | 0.01 | ||||||||||||
| Non-cash occupancy-related costs 2 | 2,151 | 0.01 | 6,757 | 0.04 | ||||||||||||
| Non-recurring costs 3 | 7,209 | 0.03 | 1,926 | 0.01 | ||||||||||||
| Non-GAAP adjusted pre-tax income (loss) / diluted earnings (loss) per share | $ | 49,933 | $ | 0.23 | $ | 24,641 | $ | 0.12 | ||||||||
| Income tax expense (benefit) at 26% normalized tax rate | 12,983 | 0.06 | 6,407 | 0.03 | ||||||||||||
| Non-GAAP Adjusted Net Income (Loss) / Adjusted EPS | $ | 36,950 | $ | 0.17 | $ | 18,234 | $ | 0.09 |
| (In Thousands, except per share amounts) | 52 Weeks Ended | |||||||||||||||
| Reconciliation of GAAP Diluted Loss per Share to Non-GAAP Diluted EPS | January 30, 2021 | February 1, 2020 | ||||||||||||||
| Amount | Per share | Amount | Per share | |||||||||||||
| GAAP net loss attributable to common stockholders / diluted loss per share | $ | (26,483 | ) | $ | (0.13 | ) | $ | (95,873 | ) | $ | (0.46 | ) | ||||
| Add (deduct): | ||||||||||||||||
| Income tax expense (benefit) | (3,337 | ) | (0.02 | ) | (35,658 | ) | (0.17 | ) | ||||||||
| Loss on debt extinguishment | 17,549 | 0.08 | ||||||||||||||
| Goodwill & indefinite-lived intangible impairment | 19,000 | 0.09 | ||||||||||||||
| Asset impairments and write offs | 15,606 | 0.07 | 11,871 | 0.06 | ||||||||||||
| Equity-based compensation | 12,915 | 0.06 | 9,489 | 0.04 | ||||||||||||
| Store pre-opening expenses | 9,228 | 0.05 | 10,325 | 0.05 | ||||||||||||
| Store closing expenses | 7,782 | 0.04 | 4,068 | 0.02 | ||||||||||||
| Severance | 5,283 | 0.03 | 10,164 | 0.05 | ||||||||||||
| Non-cash occupancy-related costs 2 | 19,240 | 0.09 | 32,763 | 0.16 | ||||||||||||
| Non-recurring costs 3 | 20,707 | 0.10 | 20,385 | 0.10 | ||||||||||||
| Non-GAAP adjusted pre-tax income (loss) / diluted earnings (loss) per share | $ | 78,490 | $ | 0.37 | $ | (13,466 | ) | $ | (0.06 | ) | ||||||
| Income tax expense (benefit) at 26% normalized tax rate | 20,407 | 0.09 | (3,501 | ) | (0.01 | ) | ||||||||||
| Non-GAAP Adjusted Net Income (Loss) / Adjusted EPS | $ | 58,083 | $ | 0.28 | $ | (9,965 | ) | $ | (0.05 | ) |
Free Cash Flow is a non-GAAP financial measure that is calculated as net cash generated by operations less cash paid
for fixed assets. Management believes that Free Cash Flow, which measures the ability to generate additional cash from business operations, is an important financial measure for use in evaluating the company s financial performance.
Although other companies report their Free Cash Flow numerous methods exist for calculating a company s Free Cash Flow. As a result, the method used by
Petco s management to calculate Free Cash Flow may differ from the methods used by other companies to calculate their Free Cash Flow.